Recombinant multi-species ANGPT4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ANGPT4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Angiopoietins are proteins with important roles in vascular development and angiogenesis. All angiopoietins bind with similar affinity to an endothelial cell-specific tyrosine-protein kinase receptor. The mechanism by which they contribute to angiogenesis is thought to involve regulation of endothelial cell interactions with supporting perivascular cells. The protein encoded by this gene functions as an agonist and is an angiopoietin. [provided by RefSeq, Jul 2008]
The Alternative Names of target: ANG-3,ANG-4,ANG3,ANG4,ANGPT4,ANGPTL4,Agpt4,Ang3,Angiopoietin-3 (ANG-3),Angiopoietin-4,Angpt4

Target products collectionGo to ANGPT4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0666-Ag-1/ GM-Tg-hg-SE0666-Ag-2 Human ANGPT4 protein Human
GM-Tg-rg-SE0666-Ag-1/ GM-Tg-rg-SE0666-Ag-2 Rat ANGPT4 protein Rat
GM-Tg-mg-SE0666-Ag-1/ GM-Tg-mg-SE0666-Ag-2 Mouse ANGPT4 protein Mouse
GM-Tg-cynog-SE0666-Ag-1/ GM-Tg-cynog-SE0666-Ag-2 Cynomolgus/Rhesus macaque ANGPT4 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0666-Ag-1/ GM-Tg-felg-SE0666-Ag-2 Feline ANGPT4 protein Feline
GM-Tg-cang-SE0666-Ag-1/ GM-Tg-cang-SE0666-Ag-2 Canine ANGPT4 protein Canine
GM-Tg-bovg-SE0666-Ag-1/ GM-Tg-bovg-SE0666-Ag-2 Bovine ANGPT4 protein Bovine
GM-Tg-equg-SE0666-Ag-1/ GM-Tg-equg-SE0666-Ag-2 Equine ANGPT4 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0666-Ag-1/ GM-Tg-hg-SE0666-Ag-2; GM-Tg-rg-SE0666-Ag-1/ GM-Tg-rg-SE0666-Ag-2;
GM-Tg-mg-SE0666-Ag-1/ GM-Tg-mg-SE0666-Ag-2; GM-Tg-cynog-SE0666-Ag-1/ GM-Tg-cynog-SE0666-Ag-2;
GM-Tg-felg-SE0666-Ag-1/ GM-Tg-felg-SE0666-Ag-2; GM-Tg-cang-SE0666-Ag-1/ GM-Tg-cang-SE0666-Ag-2;
GM-Tg-bovg-SE0666-Ag-1/ GM-Tg-bovg-SE0666-Ag-2; GM-Tg-equg-SE0666-Ag-1/ GM-Tg-equg-SE0666-Ag-2
Products Name ANGPT4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ANGPT4
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ANGPT4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.